Eyerising International is proud to introduce repeated low-level red-light therapy for slowing the progression of childhood myopia through the Eyerising Myopia Management Device. The device is non-invasive, available for children aged 3-16, and can be used either as monotherapy or in combination wit...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Address:
9-11 CLAREMONT ST. SOUTH YARRA; SUITE 2.05; MELBOURNE, VICTORIA 3141, AU
LOW
spending power
